As previously reported, compared with healthy participants, the expressions of lncRNA CEBPA-AS1, INHBA-AS1, AK001058, and UCA1 were significantly higher [15,22,28] and the expressions of PPBP and RGS18 were significantly lower [24] in the plasma of patients with EGC, indicating these as potential biomarkers for GC [15,22,24]. The gene discussed is RGS18; the disease is gastric cancer.